IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Early-stage biotech developing in-licensed therapies for kidney disease.
Industry: Health Care
Latest Trade: $1.38 0.00 (0.0%)
First Day Return: +17.0%
Return from IPO: -72.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/21/2021 |
Offer Price | $5.00 |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/12/2021 |
Offer Price | $5.00 |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Roth Capital |
Company Data | |
---|---|
Headquarters | Los Altos, CA, United States |
Founded | 2016 |
Employees | 1 |
Website unicycive.com |